Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
about
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug developmentThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisOxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesDual TNFα-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: role of protein kinase activationActivated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3βOxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachOxidative stress in older patients with bipolar disorder.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersEffect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion.Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profileFrontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy studyDefects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression.Targeting histone deacetylases for the treatment of diseaseMolecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment.Valproate and neuroprotective effects for bipolar disorder.Epigenetic treatment of neurological disease.Impaired mitochondrial function in psychiatric disorders.Targeting Huntington's disease through histone deacetylases.The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder.The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stressMitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays.Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial.Potential application of lithium in Parkinson's and other neurodegenerative diseases.Lamotrigine Attenuates Proteasome Inhibition-Induced Apoptosis by Suppressing the Activation of the Mitochondrial Pathway and the Caspase-8- and Bid-Dependent Pathways.Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.Lithium suppresses motility and invasivity of v-src-transformed cells by glutathione-dependent activation of phosphotyrosine phosphatases.Is bipolar disorder a mitochondrial disease?Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate.Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats.Pharmacological and biochemical analysis of interactions between N-acetylcysteine and some antiepileptic drugs on experimental seizures in mice.Decreased global methylation in patients with bipolar disorder who respond to lithium.
P2860
Q22241837-AC9E21B8-8C68-466B-850A-8A094C785DB1Q24651407-F5B1F3A0-C417-45F2-8CD7-76608389CC5FQ26738789-2FC14351-9D8A-4242-A480-ED8012ED03F4Q28383476-DC152CDF-06CA-4040-8035-FC2A866697A2Q28383951-5860F9EF-04E7-42D2-83AD-47FA80FFDF7FQ34084286-D17E5E83-DB32-438B-A45A-47C5BFBB5F10Q34268501-88E9C3F2-42C3-41CF-88AE-5D15DFB52062Q34585536-0624BEFC-D7F2-46AB-A6DD-C113B474971DQ35246024-429120FA-17DE-4878-AA5F-0EB276F361DFQ35624000-9A3F9A14-0CA4-4D7F-ABF1-F4259304F382Q36246448-9551D553-FC1F-4C88-8F97-1BB16C1998AFQ36295874-2792BA8D-F1B6-41A0-B16A-BC6B7A46A4D1Q37054253-3C0F5D34-499C-4A47-8D62-160E33FFF3BDQ37285247-9C84217C-F7C5-48A2-BD09-BC694FAC26D0Q37296159-736412EC-3821-47D0-909E-2A5F2E713C3AQ37639334-7184B2D1-3D0A-465B-9D21-36622CCBACDBQ37661357-1EEDA5E8-0A08-4948-9D7D-93C6D5B1FFB8Q37726041-1E3159C6-BE03-4C45-8249-1753A8FF8777Q37962584-7494AEBF-BBAD-456E-AD02-252AE0C41D77Q38003304-F9332ADA-C4AA-46DB-ACC3-EA2E3C6FEBBBQ38019159-FF041BAF-D543-4D66-A8FB-73EEF1DDA07DQ38031289-A8C6725A-A64C-448A-A9D8-4983368810E6Q38111374-7343FFB5-3CD7-4DAB-8299-45F6A5088D0CQ38213177-691105F1-936A-4134-853B-9ADA2203C2D2Q38344749-EE23FFD1-80E7-4E2D-9AE7-3E01838BB87DQ38611829-5177C0AD-3B8A-4038-8D8E-9EC35F447EAEQ38636753-D60DDEC6-FA33-4436-99C2-3E31F85E1081Q38768222-78982457-EEB1-43FC-8292-E55586F8A717Q38952933-1773DC53-8A25-4F76-A5C6-A28AAFADE55BQ39279185-FD264284-DB22-40FF-8216-3F3031C866C6Q41286620-B4F68621-BC4C-4D7A-BA31-4E034F1E6644Q42795961-B673D997-275A-4F59-BB10-5240EB963E75Q42817373-D74C4DD1-D08B-46BF-8B06-20A42FEB678EQ43152628-8D8E9B3E-40DC-4687-92D6-0F9DACD8F600Q44031099-F20AA7F8-FC15-4F6F-8F6A-AC1EF71F24A4Q46070016-A357E306-E389-478A-BFBA-896161BA094CQ47685038-531CC064-B477-48AA-AC54-07214C64181FQ47963313-99BD003C-CBAC-4A9F-98C1-D00E946285EAQ47993259-97B8E643-FA8C-45D8-A8D4-0086A84C5952Q48385192-93DAA40B-36BA-45BE-9233-0170B7A2D11E
P2860
Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of glutathione in neuropr ...... g drugs lithium and valproate.
@en
type
label
Role of glutathione in neuropr ...... g drugs lithium and valproate.
@en
prefLabel
Role of glutathione in neuropr ...... g drugs lithium and valproate.
@en
P2093
P1433
P1476
Role of glutathione in neuropr ...... ng drugs lithium and valproate
@en
P2093
P304
P356
10.1016/J.NEUROSCIENCE.2006.11.010
P407
P577
2006-12-19T00:00:00Z